Japan's PHC Corporation to work on non-melanoma skin cancer detection

Japanese firm PHC Corporation and US-based NovaScan have announced the launch of a collaboration through which they...

April 5, 2023 | Wednesday | News
AGC Biologics inks exosome agreement with Jikei University in Japan for Idiopathic Pulmonary Fibrosis project

AGC Biologics, a US-headquartered biopharmaceutical contract development and manufacturing organisation (CDMO), has sign...

April 4, 2023 | Tuesday | News
Japanese firm Takeda Pharma inks $415 M deal for celiac disease research

French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...

April 3, 2023 | Monday | News
Eppendorf adds digital documentation to connected electronic pipette system

With this innovative system, scientists can easily adjust connected pipette modes, settings, and volumes via a large tou...

March 31, 2023 | Friday | News
Fujifilm transfers EMR related business to PHC Holdings’ subsidiary in Japan

Japan-headquartered Fujifilm Corporation has announced the transfer of the electronic medical record (EMR) and medical-r...

April 3, 2023 | Monday | News
Japan's NEC establishes European subsidiaries for strengthening global AI drug development biz

Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...

March 31, 2023 | Friday | News
GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases

The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...

March 30, 2023 | Thursday | News
International dementia research collaboration to address key health challenge in Australia and Japan

Three expert teams in Australia will share $1.5 million to undertake research into causes of dementia through projects f...

March 30, 2023 | Thursday | News
Japan's Kaken Pharma inks drug discovery collaboration with bitBiome for infectious diseases

Japanese startup bitBiome, Inc. and Kaken Pharmaceuticals have signed a joint research agreement on the discovery o...

March 30, 2023 | Thursday | News
Astellas and Roche to develop integrated diabetes self-management solution in Japan

Astellas Pharma has entered into an agreement with Roche Diabetes Care Japan for the development and commercia...

March 29, 2023 | Wednesday | News
Taiwanese startup Health2Sync adds more data points to Japan's personal health record initiative

Taiwan's Health2Sync has announced that its latest version of the Health2Sync App integrates insulin data from Mallya Ca...

March 28, 2023 | Tuesday | News
Fujitsu launches new cloud-based platform for healthcare sector in Japan

Fujitsu has announced the launch of a new cloud-based platform that allows users to securely collect and leverage health...

March 28, 2023 | Tuesday | News
Takeda to invest ¥100 B in new facility for plasma-derived therapies in Japan

Takeda Pharmaceutical will invest approximately 100 billion yen (¥) to build a new manufacturing facility for plasma...

March 27, 2023 | Monday | News
Japanese startup Jolly Good and Harvard University collaborate on medical VR content

Japan-based startup Jolly Good in collaboration with Brigham and Women's Hospital, a hospital affiliated with Harva...

March 24, 2023 | Friday | News
Japan to provide comprehensive end-to-end linen management services to hospitals in India

Toyota Tsusho, a renowned global trading company within the Toyota Group in Japan, has teamed up with Tokai Corp, a spec...

March 21, 2023 | Tuesday | News
Takeda’s dengue vaccine receives first approval in Latin America

Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA  (Dengue Tetravalent Vaccine [Live, Attenuated...

March 15, 2023 | Wednesday | News
GHIT Fund invests ¥ 260 M for new malaria drug development by Japanese firms

The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 2...

March 13, 2023 | Monday | News
AriBio & Fujirebio to advance biomarker development for Alzheimer’s Disease

Fujirebio Diagnostics, Inc., (a wholly owned subsidiary of Japan-based H.U. Group Holdings, Inc. and Fujirebio Holdings,...

March 10, 2023 | Friday | News